-
Trends from the Trenches: The Capability Jump of AI and Its Impact
Bio-IT World | A year ago, some would have said AI was not making an impact on drug development or computational biology. But Sonia Timberlake, R&D strategy consultant at Timberlake & Maclsaac Biopharma Consulting, argues that recent rapid innovation makes it hard to claim AI isn’t impacting computational biology anymore.
May 7, 2026
-
Bacteria: Unsung Players in the Tumor Microbiome
Bio-IT World | How cancer patients will respond to treatment can be anticipated based on their genetics as well as the tumor microenvironment, although one relevant component is often all but dismissed: the tumor microbiota. This is despite an abundance of evidence that a cancer’s microbial community plays a major role not only in therapeutic effects but also in tumor development, progression, and metastasis formation.
May 6, 2026
-
Much Progress Needed Planning Research to Consider Sex as a Biological Variable
Bio-IT World | In 2016, the National Institutes of Health (NIH) introduced a policy requiring grantees to consider sex as a biological variable in their experimental design, analyses, and reporting. Now a team from Northwestern University has assessed progress, highlighting significant room for improvement.
May 5, 2026
-
Craig Venter, Genomics Pioneer and Visionary, Dies
Bio-IT World | The J. Craig Venter Institute (JCVI) announced that J. Craig Venter, Ph.D., the Institute’s founder, board chair, and chief executive officer, died yesterday in San Diego following a brief hospitalization for unexpected side effects that arose from treatment of recently diagnosed cancer. He was 79
Apr 30, 2026
-
Follow the Money: Autoimmune, Inflammatory Disease Therapies, Antibody-Drug Conjugates, AKT1-Selective Inhibitor Programs
Bio-IT World | Beeline Medicines debuts and advances a differentiated pipeline of precision therapies; Syneron Bio advances proprietary macrocyclic peptide discovery platform, Synova; Terremoto Biosciences advances lead AKT1-selective inhibitor programs through phase 1 clinical development; and more.
Apr 30, 2026
-
Bio-IT World Honors Four 2026 Innovative Practices Winning Projects
Bio-IT World | Bio-IT World is pleased to announce the 2026 Innovative Practices Award Winners. Prize-winning collaborations came from teams at Arizona State University, Center for Evolution and Medicine, Starfish Storage, CareDx, ASAP Discovery Consortium, Novartis, and Genedata AG.
Apr 29, 2026
-
Cepheid, Oxford Nanopore Expand Partnership, Revvity Launches New Platform, More
Bio-IT World | The first quantum genome; Cepheid and Oxford Nanopore expand their partnership; Revvity launch Signals BioDesign; PathAI and MedStar Health enter multi-year strategic collaboration; and more.
Apr 28, 2026
-
fMRI-Based Mega-Study of Psychedelics Reveals Patterns of Brain Signaling Reorganization
Bio-IT World | Psychedelics are receiving increased attention for their potential to treat various mental health conditions. Just this week, an executive order was signed directing the United States FDA, DEA, and HHS to facilitate, fund, and fast track clinical research and review of psychedelics.
Apr 23, 2026


